IvanOrlandoRosasMD

Pulmonology • Houston, TX

Critical Care Medicine

Physician

Join to view full profile

Dr. Rosas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rosas' full profile

Already have an account?

Office
7200 Cambridge St
Houston, TX 77030
Phone+1 713-798-2400

Fax+1 713-798-2688

Education & Training

Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1995 - 1998
Brooklyn Hospital CenterInternship, Internal Medicine, 1994 - 1995
National University of ColombiaClass of 1991

Certifications & Licensure

TX State Medical License 2019 - 2026
MA State Medical License 2008 - 2021
MD State Medical License 1997 - 2013
DC State Medical License 2004 - 2008
PA State Medical License 2005 - 2008

Clinical Trials

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
Completed
Phase 3

Publications & Presentations

PubMed

QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration.
Samantha Arokiasamy, Michaela J M Balderstone, Faheem Shaik, Enrico Cristante, Thomas C Moseley
British Journal of Pharmacology. 2025-02-01
1 citations
Skewed adaptive immune responses are involved in alpha-1 antitrypsin deficiency emphysema.
Joselyn Rojas-Quintero, Scott A Ochsner, Hyun-Sung Lee, Christine Cong, Alan Waich Cohen
The European Respiratory Journal. 2025-01-01
Association of Insulin Resistance With Radiographic Lung Abnormalities and Incident Lung Disease: The Framingham Offspring Study.
Sarath Raju, Paula Sierra, Vickram Tejwani, Kristen A Staggers, Meredith McCormack
Diabetes Care. 2025-01-01

Journal Articles

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Ivan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
Jay H Ryu, Deborah Assayag, Marvin I Schwarz, Paul Wolters, Andrew Gross, Ivan O Rosas, The New England Journal of Medicine

Press Mentions

Digital Atlas Created for Chronic Lung DiseaseJuly 8th, 2020
All the Ways Doctors Are Treating Coronavirus Right NowJune 23rd, 2020
Devastating Disease of the Lung Is a New Research Gift’s FocusJuly 16th, 2018
Join now to see all

Grant Support

BCM-Respiratory Research TrainingBAYLOR COLLEGE OF MEDICINE2024–2028
BCM-Respiratory Research TrainingBAYLOR COLLEGE OF MEDICINE2024–2028
Clinical Genetics and Screening for Pulmonary FibrosisBRIGHAM AND WOMEN'S HOSPITAL2016–2026
Syndecan-2 And Clinical Progression Of Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2009–2012
Syndecan-2 And Clinical Progression Of Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2008